CQ Interview: Stem Cell Science and Politics: A Talk with Elizabeth Blackburn

Elizabeth H. Blackburn, Ph.D., is a leader in the area of telomere and telomerase research—in fact, in 1984 she codiscovered the ribonucleoprotein enzyme telomerase, opening up new potentials in cancer research and therapy. This and subsequent work has earned her numerous honors, not the least of wh...

Description complète

Enregistré dans:  
Détails bibliographiques
Auteur principal: Heilig, Steve (Auteur)
Type de support: Électronique Article
Langue:Anglais
Vérifier la disponibilité: HBZ Gateway
Journals Online & Print:
En cours de chargement...
Fernleihe:Fernleihe für die Fachinformationsdienste
Publié: Cambridge Univ. Press 2005
Dans: Cambridge quarterly of healthcare ethics
Année: 2005, Volume: 14, Numéro: 2, Pages: 214-217
Accès en ligne: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)
Description
Résumé:Elizabeth H. Blackburn, Ph.D., is a leader in the area of telomere and telomerase research—in fact, in 1984 she codiscovered the ribonucleoprotein enzyme telomerase, opening up new potentials in cancer research and therapy. This and subsequent work has earned her numerous honors, not the least of which are the National Academy of Science Award in Molecular Biology, an Honorary Doctorate of Science from Yale University, the American Cancer Society Medal of Honor, and many more awards. Dr. Blackburn is a Fellow of the American Academy of Arts and Sciences, the Royal Society of London, the American Academy of Microbiology, and the American Association for the Advancement of Science. She was elected to the National Academy of Sciences, and is a Member of the Institute of Medicine.
ISSN:1469-2147
Contient:Enthalten in: Cambridge quarterly of healthcare ethics
Persistent identifiers:DOI: 10.1017/S0963180105050279